Venture capital firms and start-up founders will be watching on in alarm at the decision by a Delaware judge to scrap Elon Musk’s gargantuan package of share options that turned out to be worth close to $US56 billion ($86 billion).

After all, every founder of a start-up – whether it’s in tech or biotech – harbours dreams of one day emulating Tesla’s extraordinary commercial success.